Abilify recall: Contamination
Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-007-13
Why was Abilify recalled?
Cross Contamination with Other Products
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # AKS00623A, Exp 01/31/2026; AKS00322A, Exp 02/28/2025
- Product
- Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-007-13
- Recalling firm
- Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
- Quantity
- 108,192/30 count bottles or 7 count blister packs
- Distribution
- USA nationwide.
- Recall date
- May 1, 2024
- Classification
- Class III
- Status
- Ongoing
- Agency
- FDA (drug)